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deficiency virus (SIV), which use microglia or perivascu-Pierluigi Nicotera1
lar macrophages to accomplish neuroinvasion.MRC Toxicology Unit
The direct route for neuroinvasion (i.e., through pe-Hodgkin Building
ripheral nerves) is more unusual and is a feature of onlyUniversity of Leicester
few viral infections such as rabies and herpes. Rhabdo-Lancaster Road
viruses are introduced by an animal bite deep into softLE1 9HN Leicester
tissues. They infect muscles where replication takesUnited Kingdom
place and then reach the CNS through neuromuscular
spindles or motor end plates. Alternatively, viruses may
directly penetrate sensory nerve endings and travel
through retrograde axonal flow. Similarly, the herpesThe astonishing recognition that self-propagating
simplex virus enters the body via the skin or mucosachanges in protein structure may be at the basis of
and travels retrogradely from nerve endings to neuronalspongiform encephalopathies is changing our views
bodies in the dorsal root ganglia.of transmissible diseases. Infectious agents consisting
A new route of neuroinvasion has recently been de-of abnormally folded proteins (i.e., the prion) can prop-
scribed (Glatzel et al., 2001). Infective agents, the pri-agate in host organisms using previously unrecog-
ons, accumulate in sympathetic nerve endings withinnized routes and invade the brain after a dangerous
lymphoid organs, which are a reservoir of infectivity.liaison with the immune system. The identification of
Through sympathetic nerves, prions spread to the CNSthe nodal points of neuroinvasion and new techniques
where they replicate in neurons, causing their destruc-to amplify minute amounts of misfolded proteins may
tion in spongiform encephalopathies.open the possibility for post exposure prophylaxis.
Transmissible spongiform encephalopathies (TSEs) are
a class of fatal neurodegenerative disorders that include
King Edward of England “The Confessor” died on Janu-
Creutzfeldt-Jacob, Gerstmann-Stra¨ussler-Scheinker Syn-
ary 5, 1066, leaving no heirs. His death ignited a three-
drome, Kuru, fatal familial insomnia, and a group of animal
faction rivalry for the crown that culminated in the battle
encephalopathies including bovine spongiform enceph-
of Hastings and ended the Anglo-Saxon rule of England. alopathy (BSE). When transmitted to humans, the agent
Key to the victory of William Duke of Normandy was not that causes BSE in cattle can provoke a lethal dementia,
only the build-up of an impressive invasion fleet, but which has been defined as new variant Creutzfeldt-Jacob
also the choice of the route of invasion. While his army disease (nvCJD). Most cases of nvCJD have occurred
was calmly landing at Pevensey Bay on the southern in the UK. Iatrogenic CJD caused by corneal and dura
English coast, his rival, Harold, was fighting the Vikings mater transplantation or by administration of contami-
of King Hardrada in the north. William’s army sacked nated growth hormone preparations are likely responsi-
Sussex and established a stronghold near Hastings. ble for cases in the USA and Japan. Spongiform enceph-
After defeating Hardrada, Harold’s forces, exhausted by alopathies share in most, but not all, cases common
the battle, rushed to the south to face William’s rested pathological hallmarks including vacuolation, gliosis,
and well-organized troops. The Saxons endured for the and accumulation of a protease-resistant, misfolded
best part of a day, but despite the formidable barrier isoform of a protein termed PrP or the prion protein.
opposed by Harold’s shields to William’s archers, they About 20 years ago, Stanley B. Prusiner proposed that
were vanquished at last. transmissible spongiform encephalopathies are caused
Overcoming defenses by choosing luckily or deliber- by an agent consisting exclusively of a protein (Prusiner,
ately the best attack route is a frequent occurrence 1982). The “prion” (from proteinaceous infectious only)
in history. In complex biological organisms, physical is devoid of nucleic acids and consists of a protein
barriers are often successful in preventing pathogen capable of transforming a normal host protein (named
invasion. For example, the blood-brain barrier partially PrPc) into a misfolded self, which accumulates in the
isolates the brain from the peripheral environment, brain of scrapie-infected animals and which was termed
which decreases the risk of invasion of the nervous PrPSc. The gene that encodes PrPC was identified by
system by common pathogens. When pathogens such Charles Weissmann in hamsters and by Bruce Chesebro
as viruses find their way through, the consequences in mice and was termed PrnP in mouse and PRNP in
may be devastating. Normally, the immune system con- humans (for review, see Weissmann, 1999). The gene
stitutes a second formidable line of defense. Neverthe- was cloned in Weissmann’s laboratory, and knockout
less, ever since the Trojan horse was conceived, be- mice were generated by deleting about two-thirds of
the open reading frame (the gene is encoded by a singletrayal has been an effective method to overwhelm even
open reading frame). It turned out that Prnp/ mice didthe most obstinate defense. Indeed, cells and mediators
not develop spongiform encephalopathy when inocu-of the immune system help in delivering infectious
lated with infective prions. Also, when neuroectodermalagents to the brain, often through a weakened blood-
tissue of Prnp/ mice was grafted postnatally into thebrain barrier. Examples include HIV and simian immuno-
brain of Prnp/ mice, which were subsequently inocu-
lated intracerebrally with infective prions, only the graft
developed scrapie pathology, whereas the surrounding1 Correspondence: pn10@le.ac.uk
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tissue was spared. These findings demonstrated that cause disease after a considerably longer time than the
intracerebral route of exposure (e.g., corneal trans-the Prnp gene product (the cellular prion isoform) was
required for the onset of spongiform encephalopathy plantation). This suggested that, following peripheral in-
fection, prions would silently accumulate/replicate in(Weissmann, 1999, and references therein).
While it is well established that the cellular prion pro- peripheral organs/reservoirs and transit through at least
one PrP tissue before reaching the CNS. Prions indeedtein is necessary for development of disease and neu-
roinvasion (see below), the physical nature of the trans- replicate in lymphoid organs during the early stages of
infection (Hill et al., 1997). Within the lymphoreticularmissible agent has remained controversial. Prusiner’s
proposal that the infective agent is composed exclu- system, follicular dendritic cells (FDCs) are a prominent
site of PrPSc deposition (Kitamoto et al., 1991) both insively of the abnormally folded variant of the cellular
prion protein has been questioned by those invoking wild-type or nude mice (defective in T cell response).
The spleen is an important reservoir, where FDCs arethe existence of a mysterious partner (a virus, virino,
or other pathogens such as mycotoxin or Aspergillus). the major site of replication. Elimination of FDCs with
soluble lymphotoxin- receptor, which neutralizes BOverall, two major arguments have been used to counter
the protein-only hypothesis: (1) prions composed of the cell-mediated FDCs maturation, prevents both prion ac-
cumulation in the spleen and neuroinvasion (Montrasiosame polypeptide can evoke different brain lesions,
when propagated in inbred mice, homozygous with re- et al., 2000). Thus, in contrast with other neuroimmune
responses, T cells are not apparently involved in prionspect to Prnp, and (2) the lack of firm evidence that in
vitro conversion of purified PrPC into PrPSc results in neuroinvasion, whereas defects in differentiation and
responses of B cells suppress prion neuroinvasion (Kleininfectivity. While an in depth discussion on the nature
of the infective agent is outside the scope of this mini- et al., 1997). Because B cell defects have severe implica-
tions for FDCs maturation, two major routes for neuro-review, the recent awareness that strain specificity and
replication of infectivity can be encoded in protein struc- invasion remain possible: (1) prions reach FDCs by B cell-
independent pathways, and the B cell requirement istures can help to better understand prion invasion.
It is intriguing that clinically distinct prion diseases linked to their role in FDCs maturation; and (2) B cells
deliver prions to the spleen (in part or entirely to FDCs).can occur within the same genetically homogeneous
species, but it may be explained by the existence of Since PrP expression in B cells is not required for neu-
roinvasion (Klein et al., 1998) and at least one PrP-different conformations of the prion protein. Using anti-
bodies with differential affinity for PrPSc, Prusiner and expressing compartment must be interposed, it seemed
unlikely that B cells would directly transport prions tocolleagues have shown the existence of at least eight
different prion strains, providing evidence that strain the CNS.
Upon intraperitoneal injection with prions, replicationspecificity is encoded within the structure of PrP (Safar
et al., 1998). More recently, Chien and Weissmann have and pathological lesions appear first in the thoracic spi-
nal cord segments that receive the correspondinginvestigated the role of conformational differences in
prion strains by generating chimaeric fusions between splanchnic nerves from the sympathetic nervous sys-
tem. This suggested that the sympathetic route mightthe prion domains from two different species (Saccharo-
myces cerevisae and Candida Albicans) of a yeast prion- be the missing link between the lymphoreticular system
and the CNS. In recent experiments by Aguzzi and col-like protein, Sup 35 (Chien and Weissmann, 2001). Their
results argue that heritable prion strains derive from leagues (Glatzel et al., 2001), mice were sympathecto-
mized to produce either permanent or transient sympa-conformational differences encoded within the protein.
These findings strongly support the protein-only hy- thetic nervous system (SNS) damage. In an opposite
paradigm, mice overexpressing nerve growth factorpothesis.
In vitro generation of large amounts of PrPSc from PrPC were used to achieve SNS hyperinnervation of lymphoid
organs. Permanent and protracted sympathectomy de-has been very recently obtained by a method conceptu-
ally analogous to the polymerase chain reaction (Saborio layed or prevented the development of scrapie, whereas
hyperinnervation reduced the incubation time for scrapieet al., 2001). The ability to replicate and amplify prions
in vitro is the first demonstration that structure and bio- and increased the accumulation of prions in the spleen,
thus demonstrating that splenic nerve endings may actchemical properties of a protein can be transferred to
other proteins leading to amplification of a particular 3D as prion reservoirs. These observations set the stage
for a model of neuroimmune invasion that comprisesstructure. Although these findings are not incontrovert-
ible proof for the protein-only hypothesis, they open the two phases. The first phase is characterised by the wide-
spread colonization of lymphoreticular organs by mech-possibility of testing whether PrPSc replication causes
infectivity in vitro. anisms that depend on B lymphocytes, follicular den-
dritic cells, and possibly additional soluble factors, i.e.,The understanding that a protein can transform itself
or its kin into a deadly agent, and the evidence that a complement (Klein et al., 2001). The second phase re-
quires expression of PrPC in peripheral SNS nerves andmajor source of infectivity in humans derives from di-
etary exposure, has therefore raised the question: how results in prion dissemination in the CNS (Figure 1).
This is naturally a still incomplete model, which ac-do prions find their way to the CNS? Experiments from
Aguzzi and Weissmann showed that intraperitoneal in- counts for several observations, but has still a number
of potential missing intermediary stages. How are prionsfection in Prnp/ mice was not transmitted to the brain,
suggesting that prion transport from peripheral tissues transferred from FDCs to sympathetic nerve endings?
Additional cell types may be involved, since FDCs doto the CNS required an interposed PrP-expressing tis-
sue (Blattler et al., 1997). In addition, extracerebral infec- not establish contact with SNS terminations (Glatzel et
al., 2001). How do prions slowly replicate and traveltion (growth hormone administration) was found to
Minireview
347
Figure 1. The Route of Prion Neuroinvasion
Following absorption, most likely through the intestinal epithelium, prions reach the Peyer’s patches, probably via blood constituents (plasmino-
gen that binds PrPSc [Fisher et al., 2000] or M cells are possible candidates). Follicular dendritic cells (FDCs) are infected in the patches and
in other lymphoid organs including the spleen. One B cell-independent route that prion may use to reach the spleen involves complement
factors. Mice deficient in C3, C1q, Bf/C2, or complement receptors show partial or full protection from accumulation of prions in the spleen
after intraperitoneal exposure (Klein et al., 2001). Additional factors that are required for spreading of the infection to the CNS are a B cell-
mediated trophic stimulus for FDCs (lymphotoxin) and at least one interposed PrP tissue. According to Aguzzi and colleagues (Glatzel et
al., 2001), the sympathetic nervous system is the PrP tissue.
within SNS fibers? In principle, both axonal and nonaxo- loss of function of PrPC, following its conversion to PrPSc,
could somehow affect homo- or heterodimerization ofnal transport mechanisms may be involved. However, a
periaxonal deposition of PrPSc may suggest a nonaxonal Bcl-2, resulting in apoptotic cell death. Alternatively,
PrPSc may alter the expression of pro- and antiapoptotictransport mechanism. A conversion of PrPC into PrPSc
may be required for transport, operated by yet-unknown members of the Bcl-2 family (Park et al., 2000), which
may also result in neuronal apoptosis. However, bindingbinding proteins. Finally, the observation that hyperin-
nervated spleens are sites of enhanced prion replication and sequestration of ubiquitous members of the Bcl-2
family or changes in their expression level should alsoconfirms an early hypothesis that sympathetic nerves
are involved in accumulation and replication of prions trigger cell death in nonneuronal cells. Since PrPSc de-
posits are found in various organs with little or no patho-in lymphatic organs
Alternative routes for prion neuroinvasion have also logical alterations, brain-specific factors, other than the
Bcl-2 family members, may be more relevant. Clearly,been proposed. Replication of infectivity in lymphoid
organs may be more extensive in some species than in the largest site of prion accumulation is the nervous
system, and the size of PrPSc deposits may be crucial. Ifothers, and infectivity, in some instances, bypasses the
spinal cord (Baldauf et al., 1997). Vagal spreading lead- the probability of neuronal death depends on aggregate
accumulation (Perutz and Windle, 2001), in transmissibleing to accumulation of prions in the dorsal motor nucleus
could be an alternative route (Beekes et al., 1998). Never- prion diseases where “seeding/nucleation” is facilitated
by high levels of PrPSc, aggregates would form at a muchtheless, this trail is not used by prions in sympathecto-
mized mice (Glatzel et al., 2001). It is possible that differ- faster rate than in other neurodegenerative conditions.
Nevertheless, loss of neurons may not be the most rele-ences in prion strains and species may explain
differences in the path of neuroinvasion, although major vant event in TSEs and, while neurons remain the pri-
mary target, neuronal demise is not always the predomi-vehicles of prion spreading such as plasminogen seem
to transport prions in multiple species (Maissen et al., nant feature. The build-up of aggregates, which in other
neurodegenerative diseases correlates with the onset2001).
Understanding the route of neuroinvasion poses other of overt clinical symptoms, may initially result in loss of
connectivity and neurite degeneration causing cellfundamental questions. Why are lymphoid organs, or
other organs where prions accumulate, less prone to death only at a later stage. While a multistep degenera-
tive process can explain the partial recovery observeddamage than neurons? What is the mechanism of neuro-
degeneration? in transgenic animal models of neurodegeneration, it
challenges the current idea that neuronal loss is thePrPC binds to survival factors, including antiapoptotic
proteins like Bcl-2. It has therefore been suggested that main cause of several neurodegenerative conditions.
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Amyloid deposition and gliosis suggest that local inflam- haps they should be revisited in search of an odd patho-
matory reactions also play a relevant role in disease gen and a route for neuroinvasion.
pathogenesis. Activation of microglia (Giese and Kretz-
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It is remarkable that self-propagating changes in pro-
tein conformation may be so effective in transferring
disease across species and directing infectious agents
to target organs. Ironically, the discovery of the route
of invasion in transmissible prion diseases makes the
neuroimmune link in these recently characterized condi-
tions better understood than possible links in other neu-
roimmune diseases. Also, plausible therapies may be-
come a reality, when the pathogenetic mechanisms of
other major brain disorders are still unknown. Many hu-
man neurodegenerative diseases, for which a principle
of transmissibility has been excluded, share strikingly
similar pathological features with prion diseases. Per-
